Liquid biopsy-based monitoring of residual disease in multiple myeloma by analysis of the rearranged immunoglobulin genes–A feasibility study

The need for sensitive monitoring of minimal/measurable residual disease (MRD) in multiple myeloma emerged as novel therapies led to deeper responses. Moreover, the potential benefits of blood-based analyses, the so-called liquid biopsy is prompting more and more studies to assess its feasibility. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Marx, Anita, Osváth, Magdolna, Szikora, Bence, Pipek, Orsolya, Csabai, István, Nagy, Ákos, Bödör, Csaba, Matula, Zsolt, Nagy, Ginette, Bors, András, Uher, Ferenc, Mikala, Gábor, Vályi-Nagy, István, Kacskovics, Imre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218758/
https://www.ncbi.nlm.nih.gov/pubmed/37235573
http://dx.doi.org/10.1371/journal.pone.0285696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218758/
https://www.ncbi.nlm.nih.gov/pubmed/37235573
http://dx.doi.org/10.1371/journal.pone.0285696

Ejemplares similares